YuQi – 【國家衛生研究院】技轉及育成中心

NHRI technology, “Induction of Stem Cell-derived Exosomes for Disease Treatment” available for technology licensing (exclusive license), 2020/08/17

Latest news-English, 暫時儲存 / 2025 年 5 月 20 日 2025 年 5 月 20 日

Subject NHRI technology, “Induction of Stem Cell-derived Exosomes for Disease Treatment” (abbreviated as “The Technology”) available for technology licensing (exclusive license). Description The Technology is to use induced stem cell-derived exosomes, instead of stem cells, as regeneration medicine. The invention is a method of inducing stem cells to release exosomes carrying essential molecules for the …

NHRI technology, “Induction of Stem Cell-derived Exosomes for Disease Treatment” available for technology licensing (exclusive license), 2020/08/17 Read More »

2025 USBio- Spot Light of Recent Invention (2025/06/16)

news / 2025 年 5 月 19 日 2025 年 6 月 4 日

Cancer DBPR728/ A Kinase Inhibitor Targeting MYC Driven Cancers Abstract：Click here PowerPoint：Click here DBPR22998/ A QPCTL (IsoQC) Inhibitor Targeting CD47-SIRPα Axis for Cancer Immunotherapy Abstract：Click here PowerPoint：Click here CNS Novel Patient-Centered Diagnostic Indicators for Substance Use Disorders Abstract：Click here PowerPoint：Click here Method and composition for decreasing the psychotomimetic side effect and addictive disorder of …

2025 USBio- Spot Light of Recent Invention (2025/06/16) Read More »

2024 USBio- Spot Light of Recent Invention (2024/06/01)

news / 2024 年 5 月 19 日 2025 年 5 月 19 日

Cancer BPR5K230/ Small Molecule AXL and MERTK Dual Kinase Inhibitor as Anticancer and Immunomodulatory Agent Abstract：Click here PowerPoint：Click here DBPR117/ A Monoclonal Antibody Targeting RSPO3/Wnt Signaling – Mediated Tumorigenesis Abstract：Click here PowerPoint：Click here DBPR728/ A Kinase Inhibitor Targeting MYC Driven Cancers- A precision medicine strategy for cancers Abstract：Click here PowerPoint：Click here DBPR807/ A CXCR4-Targeted Antagonist- …

2024 USBio- Spot Light of Recent Invention (2024/06/01) Read More »

2022年獲證專利（2022 Issued）

獲證專利 / 2023 年 6 月 6 日 2023 年 6 月 6 日

Issue date Patent Title Patent No. 2022/1/4 Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine US11213495 2022/1/5 Opioid receptor modulators and use thereof MO J/005174 2022/1/5 Heterocyclic compounds and use thereof MO J/005468 2022/1/5 Heterodimeric Vascular Endothelia Growth Factor and Use Thereof EP3384029 2022/1/7 Heterocyclic compounds and use thereof …

2022年獲證專利（2022 Issued） Read More »

2023年獲證專利（2023 Issued）

獲證專利 / 2023 年 6 月 6 日 2023 年 6 月 6 日

獲證日專利名稱證號 2023/1/5 5-methoxytryptophan and its derivatives and uses thereof NZ733731 2023/1/10 Dipicolylamine derivatives and their pharmaceutical uses CA2949663 2023/1/13 Anti-Aβ antibodies and uses thereof JP7210612 2023/1/24 Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease CA3109623 2023/1/27 Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease HK40053325 …

2023年獲證專利（2023 Issued） Read More »